Visibuilt

VisibuiltVisibuilt
Visibuilt

Visibuilt

Developing biobased alternatives to conventional carbon-intensive construction binders.

Website
2022ActiveAarhus, Denmark

About

Visibuilt develops durable, fossil-free paving materials that reduce emissions and energy usage by mimicking natural infrastructure designs. Their core product, visiBINDER, is a 100% bio-based binder derived from mycelium, designed to create more natural pavements for urban designers and developers. Visibuilt offers solutions for projects ranging from parking spaces to driveways.
Frequently asked

What does Visibuilt do?

Visibuilt develops durable, fossil-free paving materials that reduce emissions and energy usage by mimicking natural infrastructure designs. Their core product, visiBINDER, is a 100% bio-based binder derived from mycelium, designed to create more natural pavements for urban designers and developers. Visibuilt offers solutions for projects ranging from parking spaces to driveways.

What is Visibuilt's revenue?

StartupHub estimates Visibuilt's annual revenue at $401K (range $111K to $1.2M, 34% confidence), based on comparable companies in the sector.

What is Visibuilt's valuation?

StartupHub estimates Visibuilt's effective valuation at $13.0M (range $8.3M to $20.0M, 23% confidence), based on comparable companies in the sector.

How much funding has Visibuilt raised?

Visibuilt has raised a total of $3M in funding. The most recent round on record is Seed.

Where is Visibuilt headquartered?

Visibuilt is headquartered in Aarhus, Denmark.

When was Visibuilt founded?

Visibuilt was founded in 2022.

What industry does Visibuilt operate in?

Visibuilt operates in Biotechnology, Construction Materials, Sustainability, HardTech, Biotech, Construction Tech.

New entrants in Biotechnology
Last 90 days
3
New entrants
1.0
Per month
0.2
Per week
Most recent
Galatek

Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.

Jul 13
Raven4batchrecords

Digital batch record software for pharmaceutical and biotech manufacturing.

Jul 9
Trofinetide

Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.

Jun 8

An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Scores
Measured, not editorial
Agent Readiness
21/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Scan this site yourself
Domain Rating
27/100

Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.

Check any domain free

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.